Mydecine Innovations Group Inc. (MYCOF)
OTCMKTS · Delayed Price · Currency is USD
0.0027
-0.0038 (-58.33%)
At close: Aug 22, 2025
MYCOF Market Cap
MYCOF has a market cap or net worth of $166.74 thousand as of August 25, 2025. Its market cap has decreased by -70.43% in one year.
Market Cap
166.74K
Enterprise Value
5.32M
Revenue
n/a
Ranking
n/a
PE Ratio
1.03
Stock Price
$0.00
Market Cap Chart
Since May 8, 2015, MYCOF's market cap has decreased from 8.91M to 166.74K, a decrease of -98.13%. That is a compound annual growth rate of -32.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 166.74K | -3.57% |
| Dec 31, 2024 | 172.92K | -77.92% |
| Dec 29, 2023 | 783.26K | -85.99% |
| Dec 30, 2022 | 5.59M | -80.55% |
| Dec 31, 2021 | 28.75M | -53.51% |
| Dec 31, 2020 | 61.86M | 1,508.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Glass House Brands | 633.65M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 368.43M |